98 related articles for article (PubMed ID: 8964396)
21. Somatostatin receptors in human renal cell carcinomas.
Reubi JC; Kvols L
Cancer Res; 1992 Nov; 52(21):6074-8. PubMed ID: 1394233
[TBL] [Abstract][Full Text] [Related]
22. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
[TBL] [Abstract][Full Text] [Related]
23. Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer.
Cianchi F; Cortesini C; Bechi P; Fantappiè O; Messerini L; Vannacci A; Sardi I; Baroni G; Boddi V; Mazzanti R; Masini E
Gastroenterology; 2001 Dec; 121(6):1339-47. PubMed ID: 11729113
[TBL] [Abstract][Full Text] [Related]
24. Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression.
Gustafsson A; Hansson E; Kressner U; Nordgren S; Andersson M; Lönnroth C; Lundholm K
Acta Oncol; 2007; 46(8):1107-12. PubMed ID: 17943472
[TBL] [Abstract][Full Text] [Related]
25. High expression of neuropeptide Y1 receptors in ewing sarcoma tumors.
Körner M; Waser B; Reubi JC
Clin Cancer Res; 2008 Aug; 14(16):5043-9. PubMed ID: 18698022
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin and other Peptide receptors as tools for tumor diagnosis and treatment.
Reubi JC
Neuroendocrinology; 2004; 80 Suppl 1():51-6. PubMed ID: 15477718
[TBL] [Abstract][Full Text] [Related]
27. Identification of a characteristic vascular belt zone in human colorectal cancer.
Kather JN; Zöllner FG; Schad LR; Melchers SM; Sinn HP; Marx A; Gaiser T; Weis CA
PLoS One; 2017; 12(3):e0171378. PubMed ID: 28253263
[TBL] [Abstract][Full Text] [Related]
28. Robo1/Robo4: differential expression of angiogenic markers in colorectal cancer.
Gröne J; Doebler O; Loddenkemper C; Hotz B; Buhr HJ; Bhargava S
Oncol Rep; 2006 Jun; 15(6):1437-43. PubMed ID: 16685377
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of the peripheral benzodiazepine receptor during human colorectal carcinogenesis and tumor spread.
Maaser K; Grabowski P; Oezdem Y; Krahn A; Heine B; Stein H; Buhr H; Zeitz M; Scherübl H
Clin Cancer Res; 2005 Mar; 11(5):1751-6. PubMed ID: 15755996
[TBL] [Abstract][Full Text] [Related]
30. Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.
Buscail L; Saint-Laurent N; Chastre E; Vaillant JC; Gespach C; Capella G; Kalthoff H; Lluis F; Vaysse N; Susini C
Cancer Res; 1996 Apr; 56(8):1823-7. PubMed ID: 8620499
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical expression of somatostatin receptor subtypes 2 and 5 in colorectal cancer.
Evangelou I; Petraki C; Msaouel P; Scorilas A; Sdrolia E; Padazi G; Koborozos V; Koutsilieris M
Eur J Clin Invest; 2012 Jul; 42(7):777-83. PubMed ID: 22304674
[TBL] [Abstract][Full Text] [Related]
32. Changes in tracheo-bronchial sensory neuropeptide receptor gene expression pattern in rats with cisplatin-induced sensory neuropathy.
Horváth P; Szilvássy Z; Peitl B; Szilvássy J; Helyes Z; Szolcsányi J; Németh J
Neuropeptides; 2006 Feb; 40(1):77-83. PubMed ID: 16343617
[TBL] [Abstract][Full Text] [Related]
33. High affinity binding sites for [3H]substance P in urinary bladders of cats with interstitial cystitis.
Buffington CA; Wolfe SA
J Urol; 1998 Aug; 160(2):605-11. PubMed ID: 9679937
[TBL] [Abstract][Full Text] [Related]
34. Somatostatin receptors in human prostate and prostate cancer.
Reubi JC; Waser B; Schaer JC; Markwalder R
J Clin Endocrinol Metab; 1995 Sep; 80(9):2806-14. PubMed ID: 7673428
[TBL] [Abstract][Full Text] [Related]
35. Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting.
Reubi C; Gugger M; Waser B
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):855-62. PubMed ID: 12111125
[TBL] [Abstract][Full Text] [Related]
36. Increase of Mast Cell-Nerve Association and Neuropeptide Receptor Expression on Mast Cells in Perennial Allergic Rhinitis.
Le DD; Schmit D; Heck S; Omlor AJ; Sester M; Herr C; Schick B; Daubeuf F; Fähndrich S; Bals R; Frossard N; Al Kadah B; Dinh QT
Neuroimmunomodulation; 2016; 23(5-6):261-270. PubMed ID: 28030866
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [177Lu-DOTA0,Tyr3]octreotate therapy.
Melis M; Forrer F; Capello A; Bijster M; Bernard BF; Reubi JC; Krenning EP; De Jong M
Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):324-33. PubMed ID: 17923824
[TBL] [Abstract][Full Text] [Related]
38. Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets.
Kaemmerer D; Schindler R; Mußbach F; Dahmen U; Altendorf-Hofmann A; Dirsch O; Sänger J; Schulz S; Lupp A
BMC Cancer; 2017 Dec; 17(1):896. PubMed ID: 29282035
[TBL] [Abstract][Full Text] [Related]
39. Roles of substance P receptors in human colon circular muscle: alterations in diverticular disease.
Liu L; Shang F; Markus I; Burcher E
J Pharmacol Exp Ther; 2002 Aug; 302(2):627-35. PubMed ID: 12130725
[TBL] [Abstract][Full Text] [Related]
40. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
